Pharmaceutical Executive, August 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2019 issue in an interactive PDF format.
Articles in this issue
A Look Back & Forward on Innovation
Routes to Exclusivity in Cell-Based Therapy Development
Gene Therapy: Managing the Clinical Trial Minefields
The Call to Cure: Geoff MacKay, AVROBIO
Four Takeaways from the Zolgensma Pricing Storm
FDA Faces ‘Explosion’ in Growth of Gene Therapies
Mapping Out the Future of Cell and Gene Therapy
High-Stakes Manufacturing: Mitigating the Risks
Gene Therapy: How ‘Advanced’ is Europe?
Luxturna: A Vision for Curative Therapy Access
Can EU Seize the Chance of Pooling Genomic Data?
The Shrinking Disconnect in Digital Therapeutics
Three Tips to Managing Multiple Agency Partners
Using FDA’s ‘PIE’ Recipe to Enhance Patient Access
Pharmaceutical Executive, August 2019 Issue (PDF)
Recent Videos
Related Content
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Podcast
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
